GlassScriptPhysician profile
Scot D Miller
NPI 1861574196
$404,158.84
in general payments reported to CMS, 2019-2025
12 companies · $33K in 2025
The $33K reported for 2025 was more than what 83% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $188K · 2021: $46K · 2022: $43K · 2023: $41K · 2024: $8,340 · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $81K · Travel and Lodging: $1,005 · Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $80,863.14 |
| Travel and Lodging | $1,005.20 |
| Food and Beverage | $428.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $175,000.00 | 2019-2023 | Magellan |
| Wishbone Medical INC. | $148,088.77 | 2020 | |
| Carbofix Spine INC | $40,863.14 | 2024-2025 | |
| Spineart USA INC | $13,485.92 | 2021-2022 | |
| Medacta USA, INC. | $13,411.44 | 2019 | |
| Zimmer Biomet Holdings, INC. | $6,138.00 | 2019 | |
| Innovasis INC | $3,679.00 | 2022 | |
| Medtronic, INC. | $2,241.97 | 2022-2025 | Mazor X System |
| Intuitive Surgical, INC. | $1,005.20 | 2023 | Da Vinci Surgical System |
| Horizon Therapeutics Plc | $119.90 | 2019 | |
| Back 2 Basics Direct, LLC | $112.26 | 2019 | |
| Globus Medical, INC. | $13.24 | 2023 | Excelsiusgps Robotic Navigation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$79,743.73 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scot Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.